Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10415 (
Bcl-2
)
33,771
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Understanding intracellular transduction pathways on apoptosis is indispensable for clinical application to develop effective cancer therapies. Transcription factor p53 is activated in response to genotoxic damage and plays crucial roles in apoptosis. p53 regulates the expression of numerous apoptosis-related genes to induce cell death. Here, through genome-wide comprehensive gene expression profile, we identified
D4S234E
as a novel p53-responsive gene. We determined the p53-binding region in the
D4S234E
promoter, which is important for p53 regulation in response to DNA damage. Inhibition of
D4S234E
expression by RNA interference suppressed apoptosis. Furthermore, we observed that
D4S234E
partially localizes in the endoplasmic reticulum (ER). We found a functional ER retention signal in
D4S234E
and, more importantly, ER targeting is essential for
D4S234E
-mediated apoptosis. Finally, depletion of
D4S234E
diminished genotoxic stress-induced reduction of
Bcl-2
and augmentation of CHOP. We thus concluded that a novel p53-responsive gene
D4S234E
is accumulated in the ER and induces apoptosis in response to DNA damage.
...
PMID:D4S234E, a novel p53-responsive gene, induces apoptosis in response to DNA damage. 2059 42